Novartis Pharmaceuticals has announced the discontinuation of Estraderm TTS 25® (estradiol) and Estraderm TTS 100® (estradiol) patches for commercial reasons as of 1st January 2011. Based on current usage patterns it is anticipated that some stock will continue to be available throughout early 2012. Patients are advised to consult their doctor for advice on their treatment. For further information, contact the Medical Information Department on 01276 698370.